BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8895991)

  • 1. Epidemiology of human aflatoxin exposures and their relationship to liver cancer.
    Groopman JD; Scholl P; Wang JS
    Prog Clin Biol Res; 1996; 395():211-22. PubMed ID: 8895991
    [No Abstract]   [Full Text] [Related]  

  • 2. Impacts of chemicals on liver cancer risk.
    Wogan GN
    Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 gene of chang-liver cells (Atcc-Ccl13) exposed to aflatoxin B1 (Afb): the effect of lysine on mutation at codon 249 of exon 7.
    Uwaifo O
    Afr J Med Med Sci; 1999; 28(1-2):71-5. PubMed ID: 12953991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology of malignant liver tumors].
    Rodella S; Picoco C
    Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
    Groopman JD; Wang JS; Scholl P
    Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aflatoxins as risk factors for hepatocellular carcinoma in humans.
    Wogan GN
    Cancer Res; 1992 Apr; 52(7 Suppl):2114s-2118s. PubMed ID: 1311989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
    Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
    Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
    McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH
    Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China.
    Shimizu Y; Zhu JJ; Han F; Ishikawa T; Oda H
    Int J Cancer; 1999 Jul; 82(2):187-90. PubMed ID: 10389750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure biomarkers in chemoprevention studies of liver cancer.
    Wild CP; Turner PC
    IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 proteins and aflatoxin b1: the good, the bad, and the ugly.
    Liang TJ
    Hepatology; 1995 Oct; 22(4 Pt 1):1330-2. PubMed ID: 7557889
    [No Abstract]   [Full Text] [Related]  

  • 13. RASSF1A hypermethylation is associated with aflatoxin B1 and polycyclic aromatic hydrocarbon exposure in hepatocellular carcinoma.
    Feng Y; Xue WJ; Li P; Sha ZY; Huang H; Rui L; Li HX; Mao QS
    Hepatogastroenterology; 2012 Sep; 59(118):1883-8. PubMed ID: 22172412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sequence alterations in p53 gene of hepatocellular carcinoma from high aflatoxin risk area in Guangxi].
    Deng Z; Pan L; Ma Y
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):18-21. PubMed ID: 10743047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin as a cause of primary liver-cell cancer in the United States: a probability study.
    Stoloff L
    Nutr Cancer; 1983; 5(3-4):165-86. PubMed ID: 6322137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural occurrence of aflatoxins in Chinese peanut butter and sesame paste.
    Li FQ; Li YW; Wang YR; Luo XY
    J Agric Food Chem; 2009 May; 57(9):3519-24. PubMed ID: 19338351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aflatoxin and liver cancer.
    Jackson PE; Groopman JD
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):545-55. PubMed ID: 10654919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations in nonmalignant human liver: fingerprints of aflatoxins?
    Ozturk M
    Hepatology; 1995 Feb; 21(2):600-1. PubMed ID: 7843737
    [No Abstract]   [Full Text] [Related]  

  • 19. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
    Lasky T; Magder L
    Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.